Back to Authors

Liu, R.

A5029491646 | I4405270001

Mayo Clinic

Takeda Oncology (United States)

Citations 1

EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 290-291

10.1002/hon.99_2630